= Abstract = Hepatomegaly and liver dysfunction might develop in patients with diabetes mellitus due to glycogen deposition or nonalcoholic steatohepatitis. We experienced a case of hepatic glycogenosis in a patient with type 1 diabetes mellitus who presented with recurrent hypoglycemia, suggesting impairment of glycogenolysis and gluconeogenesis. A 10-year-old girl with a 4-year history of type 1 diabetes mellitus was admitted because of recurrent hypoglycemia and abdominal pain in the right upper quadrant. She had Cushingoid features and hepatomegaly that extended 6 cm below the right costal margin. Laboratory data and radiologic examination revealed elevated liver enzyme levels due to fatty liver. Periodic acid-Schiff (PAS) staining revealed intense glycogen deposition in the cytoplasm of the hepatocytes and PAS reactivity was lost with diastase treatment. At 2 months after administration of glucagon injection and uncooked cornstarch between meals and at bedtime, the hypoglycemic episodes and liver dysfunction improved. It is important to distinguish hepatic glycogenosis from steatohepatitis, because it is possible to prevent excessive hepatic glycogen storage in hepatic glycogenosis cases by strictly controlling blood glucose level and by glucagon administration. To prevent severe hypoglycemic symptoms accompanied by hepatic glycogenosis, we suggest that uncooked cornstarch, which is effective in maintaining blood glucose level, can also be administered. (Korean J Pediatr 2009;52:1279-1282 
Introduction
Hepatomegaly and hepatic dysfunction in patients with diabetes mellitus can be caused by excessive hepatic glycogen deposition or nonalcoholic steatohepatitis (NASH).
The frequency of hepatic glycogenosis in patients with type 1 diabetes mellitus is relatively rare in children who undergo insulin therapy. The clinical features of hepatic glycogenosis in type 1 diabetes mellitus are hepatomegaly, hypoglycemia, elevated transaminase, hyperlipidemia and ketosis 1) . It is important to distinguish between hepatic glycogenosis and NASH, because hepatic glycogenosis can be reversed by strict blood glucose control and glucagon Moreover, NASH is a progressive disease that may lead to fibrosis or cirrhosis of the liver, while hepatic glycogenosis is not known to cause fibrosis or cirrhosis 1, 2) . We experienced a case of hepatic glycogenosis in a girl with poorly controlled type 1 diabetes mellitus who presented with recurrent hypoglycemia and hepatomegaly, which suggested impaired glycogenolysis and gluconeogenesis.
Case report
A 10-year-old girl, who was diagnosed with type 1 diabetes mellitus at 6 years of age, was admitted because of recurrent hypoglycemia and right upper quadrant pain. However, hepatomegaly had not been improved after 2 months of treatment.
Discussion
Long-standing hyperglycemia, overinsulinization, glucose given to control hypoglycemia, and increased concentrations of the counterregulatory hormones are the risk factors for hepatic glycogenosis in patients with type 1 diabetes mellitus by their concerted actions on the glycogen phosphorylase and synthase enzymes [3] [4] [5] . In 1930, noticeable hepatomegaly due to excessive hepatic glycogen accumulation and hepatic dysfunction in patients with poorly controlled type 1 diabetes mellitus was identified and referred to as Mauriac syndrome 6) . So far, three cases of Mauriac syndrome have been reported in the literature in Korea [7] [8] [9] . A typical Mauriac syndrome presents pro-A B . Decreased glycogenolysis is also a cause of hepatic glycogenosis. Phosphorylase kinase activate glycogen phosphorylase, which is associated with glycogenolysis. However, prolonged hyperglycemia leads to inactivation of phosphorylase kinase 10) . Hepatic glycogenosis can also occur as one of the early manifestations in type 1 diabetes mellitus 11) . In adults with type 1 diabetes mellitus, two cases of hepatic glycogenosis have been reported in Korea 10, 12) . However, this is the first case of hepatic glycogenosis in a child with type 1 diabetes mellitus in Korea. Hepatic glycogenosis in type 1 diabetes mellitus is a benign disease with little chance of progression to fibrosis or cirrhosis, and readily treatable by improvement of glycemic control in a few weeks to months. Minimum dosage of insulin and glucagon injection is required for regression of hepatomegaly and better metabolic control 5) .
To prevent severe hypoglycemic symptoms accompanied by hepatic glycogenosis, uncooked cornstarch can be used and was effective in maintaining blood glucose concentrations. Uncooked cornstarch has been studied extensively in glycogen storage disease and diabetes mellitus. There have been several reports that used uncooked cornstarch as a bedtime snack to prevent nocturnal hypoglycemia in patients with type 1 diabetes mellitus [13] [14] [15] . When hypoglycemia becomes prolonged, the use of glucagon will reduce the amount of glucose administered, and perhaps reduce the amount of glycogen stored in the liver 5) . 
